期刊文献+

53例肺纤维化合并肺癌患者的临床特征及生存分析 被引量:6

Analysis on the Clinical Characteristics and Survival of 53 Patients with Pulmonary Fibrosis Complicated with Lung Cancer
原文传递
导出
摘要 目的总结肺纤维化(PF)合并肺癌(LC)的临床特征,分析PF-LC患者的预后和影响因素。方法收集2008年1月至2014年3月期间住院PF患者中确诊LC患者53例,采用Cox回归模型分析多种临床因素对生存的影响;并通过Kaplan-Meier法计算中位生存期(MST)及总生存时间(OS),绘制生存曲线,比较不同临床因素对预后的作用。结果 53例PF-LC患者中,男性(n=48,90.6%)及吸烟(n=42,79.2%)患者多见,平均年龄(68.6±9.5)岁。通过Cox回归模型,对年龄、吸烟史、胸痛、Velcro啰音、PF类型、LC临床分期、LC治疗等因素分析显示,Velcro啰音(P=0.009)及临床分期(P=0.013)是PL-LC患者预后的独立影响因素。全组患者MST为6.0个月,1年、2年生存率分别为34.1%、22.0%。53例患者中,特发性PF-LC 42例(79.2%),继发性PF-LC 11例(20.8%);两组OS差异无统计学意义。不同LC病理类型患者中,NSCLC组(n=37)的OS较SCLC(n=6)及未分类组(10例)显著延长(P=0.035)。不同LC临床分期患者,Ⅰ期+Ⅱ期患者(n=13)较Ⅲ期+Ⅳ期患者(n=40)OS显著延长(P=0.002)。治疗上,针对LC治疗组(n=31)较未治疗组(n=22)MST及OS均显著延长(P<0.001);采取综合治疗方案组(n=11)较单一方案治疗组(n=20)的OS显著延长(P=0.036)。结论 Velcro啰音及LC临床分期是影响PF-LC患者预后的独立危险因素。治疗上,建议针对LC采用综合治疗方案,以延长患者的生存期。 Objective To analyze the clinical characteristics and survival of pulmonary fibrosis( PF) patients complicated with lung cancer( LC)( PL-LC). Methods Fifty-three patients with PF diagnosed as LC from January 2008 to March 2014 in Nanjing Drum Tower Hospital were included in this study. Univariate analysis and Cox regression analysis were used to detect the effects of clinical variables on survival. Kaplan-Meier method was used to calculate the median survival time( MST) and overall survival( OS). Results Male patients( n = 48,90. 6%) and patients with a history of smoking( n = 42,79. 2%)were more easily suffered from PF-LC. The average age was 68. 6 ± 9. 5 years. Cox multivariate analysis revealed that Velcro crackles( P = 0. 009) and clinical stage( P = 0. 013) were the independent risk factors of survival in the patients with PF-LC. The MST of 53 patients was 6. 0 months. The survival rates of 1-year and 2-year were 34. 1% and 22. 0%,respectively. Forty-two( 79. 2%) patients were idiopathic pulmonary fibrosis( IPF) complicated with LC,and 11( 20. 8%) patients were secondary pulmonary fibrosis( SPF)complicated with LC. OS difference between two groups was not significant( P = 0. 610). OS of NSCLC group( n = 37) was significantly prolonged than that of SCLC group( n = 6) and unclassified pathological pattern group( n = 10)( P = 0. 035). OS of Ⅰ and Ⅱstage patients( n = 13) was significantly longer than that of Ⅲ and Ⅳ stage patients( n = 40)( P = 0. 002). MST and OS of patients with LC treated( n = 31)were significantly better than those of untreated patients( n = 22)( P〈 0. 001) and OS of patients treated by comprehensive therapy( n = 11) was significantly prolonged than that of patients treated by mono-therapy( n = 20)( P = 0. 036). Conclusions Velcro crackles and clinical stages are the independent risk factors of prognosis in PF-LC patients. It is beneficial to survival if the PF patients wit
出处 《中国呼吸与危重监护杂志》 CAS 北大核心 2016年第3期216-221,共6页 Chinese Journal of Respiratory and Critical Care Medicine
基金 国家自然科学基金青年基金(编号:81200049) 江苏省政府留学奖学金(编号:JS-2013-060)
关键词 肺纤维化 肺癌 生存时间 临床特征 Pulmonary fibrosis Lung cancer Survival Clinical variables
  • 相关文献

参考文献25

  • 1Bouros D, Hatzakis K, Labrakis H, et al. Association of malignancy with diseases causing interstitial pulmonary changes. Chest ,2002,121 : 1278-1289. 被引量:1
  • 2Watanabe N, Tanignchi H, Kondoh Y, et al. Efficacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fibrosis. Respiration,2013,85:326-331. 被引量:1
  • 3Wells C, Mannino DM. Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991. South Med J,1996,89:505-510. 被引量:1
  • 4Raghu G, Collard HR, Egan J J, et al. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med,2011,183 :788-824. 被引量:1
  • 5蔡后荣.对特发性肺纤维化诊断和治疗循证指南的几点刍议[J].中华结核和呼吸杂志,2012,35(2):156-157. 被引量:4
  • 6蔡后荣.特发性肺纤维化临床研究中亟待关注的问题[J].中华结核和呼吸杂志,2010,33(12):881-883. 被引量:2
  • 7Bohan A, Peter JB. Polymyositis and dermatomyositis. New Engl J Med, 1975,292(7-8 ) :344-347,403-407. 被引量:1
  • 8Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjfigren' s syndrome : a data-driven, expert consensus approach Collaborative Clinical Alliance (Hoboken) ,2012,64:475-487. 被引量:1
  • 9in the Sjsgren' s International cohort. Arthritis Care Res Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheum,2010,62:2569-2581. 被引量:1
  • 10Jennette JC, Falk ILl, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum,2013,65 : 1-11. 被引量:1

二级参考文献47

  • 1American Thoracic Society,European Respiratory Society.American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.This joint statement of the American Thoracic Society (ATS),and the European Respiratory Society (ERS) was adopted by the ATS board of directors,June 2001 and by the ERS Executive Committee,June 2001.Am J Respir Crit Care Med,2002,165:277-304. 被引量:1
  • 2Martinez FJ,Safrin S,Weycker D,et al.The clinical course of patients with idiopathic pulmonary fibrosis.Ann Intern Med,2005,142(12 Pt 1):963-967. 被引量:1
  • 3Azuma A,Nukiwa T,Tsuboi E,et al.Double-blind,placebocontrolled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.Am J Respir Crit Care Med,2005,171:1040-1047. 被引量:1
  • 4Churg A,Müller NL,Silva CI,et al.Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibroticinterstitial pneumonias.Am J Surg Pathol,2007,31:277-284. 被引量:1
  • 5Kim DS,Park JH,Park BK,et al.Acute exacerbation of idiopathic pulmonary fibrosis:frequency and clinical features.Eur Respir J,2006,27:143-150. 被引量:1
  • 6Collard HR,Moore BB,Flaherty KR,et al.Acute exacerbation of idiopathic pulmonary fibrosis.Am J Respir Crit Care Med,2007,176:636-643. 被引量:1
  • 7Parambil JG,Myers JL,Ryu JH.Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy.Chest,2005,128:3310-3315. 被引量:1
  • 8Yüksel M,Ozyurtkan MO,Bostanci K,et al.Acute exacerbation of interstitial fibrosis after pulmonary resection.Ann Thorac Srug,2006,82:336-338. 被引量:1
  • 9Kondoh Y,Taniguchi H,Kawabata Y,et al.Acute exacerbation in idiopathic pulmonary fibrosis.Analysis of clinical and pathologic findings in three cases.Chest,1993,103:1808-1812. 被引量:1
  • 10Lettieri CJ,Nathan SD,Barnett SD,et al.Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.Chest,2006,129:746-752. 被引量:1

共引文献15

同被引文献58

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部